S100 calcium-binding protein A7-like 2 (S100A7L2)

S100 calcium-binding protein A7-like 2 (S100A7L2) is a locus categorized as a non-transcribed pseudogene in humans, meaning it is not believed to produce a functional RNA or protein under physiological conditions. Although it contains an intact coding sequence, there is no evidence of its transcription or protein expression, and only a small portion of the regulatory region seen in related, functional S100 genes is present. S100A7L2 is part of the S100 protein family, which are calcium-binding proteins with roles in cell cycle progression and differentiation, but S100A7L2 itself is not considered biologically active or therapeutically relevant at this time[3][8].\n\nKey context:\n- S100A7L2 is not considered a therapeutic target, enzyme, receptor, or biomarker, nor is it implicated in disease or drug interaction, as it is not expressed or functional[3][8].\n- If your intention was to investigate S100A7 (S100 calcium-binding protein A7), a functional family member involved in inflammation and cancer, this entry is distinct; S100A7L2 is a pseudogene, not a functional gene product[3][8].\n\nThus, S100A7L2 should not be treated as a conventional pharmacological or biological target.

Other names

S100A7L2S100A7Bs100a7bProtein S100-A7-like 2S100 calcium-binding protein A7-like 2